Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Probi continues market expansion in APAC – new approval in Thailand

Probi has received approval from the Thai FDA for the bacterial strain Lactiplantibacillus plantarum HEAL9™. This provides Probi the opportunity to launch the Probi[®] Osteo and Probi Defendum[®] concepts on the expansive Thai market.After a two-year process, Probi has also had HEAL9™ approved, after HEAL19™ was approved in autumn 2022 by the Thai FDA. Both probiotic strains are included in Probi's concepts Probi[®] Osteo and Probi Defendum[®]. The plan is now to launch both concepts in the Thai market within the next 12 months. Thailand is one of the largest markets for probiotics in

Solid performance in a volatile financial market

During the first three months of 2023, the Nordic Investment Bank (NIB) continued to see a strong demand for its lending and disbursements in line with the Bank’s plans. NIB signed a total of EUR 432 million in new lending and disbursed EUR 889 million. The new lending was distributed across different sectors and countries. Earnings continued to improve and net interest income increased by 38% compared to the same quarter in 2022. NIB has raised EUR 3.8 billion in new funding so far in 2023. In March, NIB priced a five-year USD 1.5 billion global benchmark bond, which attracted one

Change in number of shares and votes in Evolution AB (publ)

During April 2023, 41,768 new shares in Evolution AB (publ) have been issued through the exercise of 90,800 warrants of series 2020/2023.As of 28 April 2023, following the exercise of the warrants set out above, the number of shares and votes in Evolution AB (publ) amount to 215,604,777. For further information, please contact:Jacob Kaplan, CFO, ir@evolution.com. This information is such that Evolution AB (publ) is obliged to publish according to the Swedish Financial Instruments Trading Act. This press release was submitted for publication by the person above on 28 April 2023 at 09:

Crunchfish are nominated for Outstanding Advancement in Digital Currency and the Fintech Innovation Showcase

Crunchfish have been nominated as finalist for the Digital Currency Awards in the category Outstanding Advancement in Digital Currency. This award recognizes the most exciting digital currency business of the year, one that has made a huge impression in the space with new and innovative services. Crunchfish has also been selected to pitch at the Fintech Innovation Showcase at the Digital Currency Conference (DCC) in Mexico City which Crunchfish CEO Joachim Samuelsson attends as a speaker and panelist. Crunchfish are invited to attend the Digital Currency Awards 

Change in Valmet’s Executive Team

Valmet Oyj’s press release April 28, 2023 at 10:00 a.m. EESTMr. Tero Kokko, Ph.D. (Eng.), M.Sc. (Econ), has been appointed President, EMEA (Europe, Middle East, Africa) at Valmet as of June 1, 2023. In his new position, Tero Kokko is a member of Valmet's Executive Team and reports to President and CEO Pasi Laine.Tero Kokko currently works in Valmet's Services business line as Vice President, Fabrics business unit, where he started in 2020. Prior to this, he worked in various management positions at Cargotec and its subsidiary Kalmar since 2011 and in Metso's Automation business between

Dollar Bill Y'All - Spring Records And The First Decade Of Hip Hop

In 1979, Spring Records released the first hip-hop style rap record ‘King Tim III (Personality Jock)’ by The Fatback Band. The label, initially relegated it to the B-Side, instead allowing the Sugarhill Gang the breakthrough rap hit with ‘Rapper’s Delight’. Over the next decade, Spring kept dipping their toes in the water, but without any great conviction or mainstream success - but they were always there to chart hip-hop’s development. “Dollar Bill Y’All” focuses on all the key moments and includes personality jocks like Mr. Magic, street tough rapping, live funk bands and the birth of

Targovax ASA - Notice of Annual General Meeting

The Annual General Meeting of Targovax ASA (the “Company”) will be held at the Company’s offices at Lysaker, on 22 May 2023 at 14:00 CET. Notice of attendance Notice of attendance must be received no later than 19 May 2023 at 16:00 CET. Casting of advance votes and submission of proxies must be received no later than 19 May 2023 at 16:00 CET. Attached you will find the notice to the General Meeting, including appendices. The notice and appendices will also be made available on Targovax’ website https://www.circio.com/en/section/governance/general-meetings/. TRVX - Notice AGM

The subscription price for the warrants of series TO6 in Svenska Aerogel Holding AB (publ) has been determined to SEK 0.22 and the exercise period starts May 2, 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SOUTH AFRICA, SOUTH KOREA, BELARUS, RUSSIA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. Svenska Aerogel Holding AB (publ) ("Svenska Aerogel" or "the Company") completed a rights issue of units on Nasdaq First North Growth Market in October 2022. Each unit

Brain+ publishes its Annual Report 2022, highlighting important milestones and financial performance as expected

COMPANY ANNOUNCEMENT  Copenhagen, Denmark, April 28, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+, a digital dementia therapeutics company, has today published its annual report for 2022, includingBusiness highlights for 2022  ·A Danish version of the company’s first product, CST - Therapist Companion was finalized for advanced market entry and the first commercial contract with a municipal dementia institution was closed.  ·The development of a German version of CST - Therapist Companion was accelerated and the first of three milestones in the partnership with

BioStock: Ultimovacs updates INITIUM study timeline

The phase II INITIUM trial with Ultimovacs’ universal cancer vaccine UV1 in malignant melanoma was due for a data readout in the first half of 2023. However, disease progression is taking longer than expected, which is a good sign for patients in such a high risk group. The company has thus updated guidance for a readout to the second half of 2023. BioStock spoke with Ultimovacs’ CEO Carlos de Sousa to learn moreRead the interview with Carlos de Sousa at biostock.se: Ultimovacs updates INITIUM study timeline - BioStock 

Annual Report 2022 for Brain+ A/S

Brain+ annual report for 2022 is now available on the Company´s websiteThe annual report including the auditor’s report is available as an attached file and can also be read on the Company's website at http://www.brain-plus.com/investor/announcements_and_financial_documents/  Contact Information: Kim Baden-Kristensen, CEO Phone: +45 31393317 E-mail: kim@brain-plus.com   www.brain-plus.com Certified Adviser  Keswick Global AG  Phone: +43 1 740 408 045  E-mail: info@keswickglobal.com

Wyld Networks announces multi-operator capability for satellite IoT

Wyld Networks announce a new release of Wyld Connect and Wyld Fusion to support multi-operator capability for satellite IoT. The new release of Wyld Connect reduces latency and increases capacity for delivering data via our partnerships with satellite operators Eutelsat and Lacuna. The new release of Wyld Fusion provides one platform for our customers to seamlessly manage their data across multiple constellations.Each of our satellite operator partners has their own Low Earth Orbit satellite constellation. Wyld can communicate with each of these constellations from the one Wyld Connect

Angler Gaming PLC published its Annual and Sustainability Report 2022

Thomas Kalita, CEO, comments: “2022 was a very challenging year. Seeing poor results in Q1 2022, I took an additional role of Acting Operational CEO to lead the execution of the improvement action plan. The execution of this plan in 2022 has led to the re-positioning of the Group’s proprietary I-Gaming platform, an increased focus on B2B offerings, tightened cost controls, embracing new business verticals and further investment in the most important asset – our human capital, which proved instrumental in our turn-around plan. The hard work has started to bear fruit in 2023, which began

Addtech acquires Electrum Automation AB

Addtech Electrification, a business area in the Addtech Group, has signed an agreement to acquire 100 % of the shares outstanding in Electrum Automation AB (“Electrum”). Electrum develop, produce and sell mobile electronics and complete solutions to leading manufacturers of machines and vehicles. Electrum is headquartered in Umeå, Sweden, has 22 employees and annual sales of approximately SEK 80 million. With its experience of electronics and software design and broad expertise in system integration, the company will complement Addtech's business unit Connectivity Solutions in a very

Atlas Copco Group awards recognize innovation, marketing, and operational excellence

Nacka, Sweden, April 28, 2023: This year, the Atlas Copco Group awards recognize an innovation related to the sealing of EV batteries, promotional activities for electric portable air compressors and innovative solutions that improve the semiconductor supply chain.“The winners of this year’s awards have shown examples of excellent teamwork by presenting innovative solutions that increase the value for our customers,” said Mats Rahmström, President and CEO of the Atlas Copco Group. “The awards are tangible examples of how we are part of the transformation to a low carbon society through our

Dicot AB publishes the Annual Report 2022

Press release: Uppsala, Sweden, April 28, 2023. The annual report of Dicot AB (publ) for 2022 has been published today and is available on www.dicot.se  and as an attachment to this press release. Our financial reports are available on www.dicot.se/en/investor-relations/reports-and-issues/For further information, please contact: Elin Trampe, CEOPhone: +46 739 80 14 08                                             E-mail: elin.trampe@dicot.se Björn Petersson, CFOPhone: +46 761 09 00 00E-mail bjorn.petersson@dicot.se About Dicot AB Dicot is

INVITATION: INVISIO invites you to a conference call May 5[th] at 10:00 CEST

INVISIO is pleased to invite press, investors and analysts to a conference call on May 5[th] at 10.00 CEST, where CEO Lars Højgård Hansen will present the Interim Report January-March 2023.The conference call, which will be held in English, will begin with a presentation of the report followed by a Q&A session. The report will be published on May 4[th], 2023, at 11:00 CEST. A replay of the call, the presentation and the Interim Report can be found on www.invisio.com. Register for the conference To participate in the conference call, prior registration is required. After

Interim report January – March 2023

NET ASSET VALUE AND THE LATOUR SHARE · The net asset value rose to SEK 186 per share, compared with SEK 159 per share at the start of the year. This is an increase of 17.2 per cent. By comparison, the Stockholm Stock Exchange’s Total Return Index (SIXRX) increased by 8.7 per cent. The net asset value was SEK 186 per share at 27 April.[1] · The total return on the Latour share was 6.9 per cent during the period measured against the SIXRX, which rose 8.7 per cent. INDUSTRIAL OPERATIONS · The industrial operations’ order intake rose 8 per cent to SEK 6,320 m (5,840 m). Adjusted

Truecaller AB (publ) publishes Annual Report for 2022

Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, has today published its Annual Report and Sustainability Report for 2022.The report is available for download at corporate.truecaller.com . The Swedish Annual Report is available in European Single Electronic Format (ESEF) on Truecaller's website. For more information, please contact: Andreas Frid, Head of IR & Communication +46 705 29 08 00andreas.frid@truecaller.com This information is

Interim Report 1 January - 31 March 2023

• 53% increase in gross order intake and 56% increase in net sales compared to the corresponding quarter of the previous year• Continued growth in user base globally and continued increase in clinical acceptance• Distribution network established in the US ”In the first quarter of 2023, we experienced our best quarter to date in all respects, with higher sales (+56%), greater gross order intake (+53%) and more customers (+20%). On a rolling 12 months basis, the user base, i.e. the number of orthopaedic surgeons who use Episealer®, increased by 46% (105), and user base growth is of

Notice of Extraordinary General Meeting in Starbreeze AB (publ)

The shareholders of Starbreeze AB (publ), Reg. No. 556551–8932, are given notice of the Extraordinary General Meeting to be held on Wednesday 24 May 2023 at 10.00 in Celsiussalen, Citykonferensen, Malmskillnadsgatan 46, Stockholm, Sweden. Registration for the meeting starts at 09.30.The Board of Directors has decided that shareholders shall be able to exercise their voting rights at the Extraordinary General Meeting also by postal voting in accordance with the regulations in Starbreeze's Articles of Association. Right to participate and notification Participation in the meeting room

Notice of annual general meeting of Calliditas Therapeutics AB (publ)

The shareholders of Calliditas Therapeutics AB (publ) (“Calliditas Therapeutics”), Reg. No. 556659-9766, with registered office in Stockholm, are summoned to the annual general meeting on Tuesday 30 May 2023 at Klara, Klarabergsviadukten 90, Stockholm, Sweden. Registration starts at 10.00 CEST.Right to participate in the annual general meeting and notice of participation Participation in the annual general meeting at the venue A shareholder who wishes to participate in the annual general meeting at the venue in person or represented by a proxy must (i) be recorded as a shareholder in

There are no items matching the current filter
There are no more items matching the current filter
Back to top